<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Protein Cell</journal-id>
<journal-id journal-id-type="iso-abbrev">Protein Cell</journal-id>
<journal-title-group>
<journal-title>Protein &amp; Cell</journal-title>
</journal-title-group>
<issn pub-type="ppub">1674-800X</issn>
<issn pub-type="epub">1674-8018</issn>
<publisher>
<publisher-name>Higher Education Press</publisher-name>
<publisher-loc>Beijing</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27245166</article-id>
<article-id pub-id-type="pmc">4930766</article-id>
<article-id pub-id-type="publisher-id">272</article-id>
<article-id pub-id-type="doi">10.1007/s13238-016-0272-7</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>MiR-130a regulates neurite outgrowth and dendritic spine density by targeting MeCP2</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Yunjia</given-names>
</name>
<xref ref-type="aff" rid="Aff1"></xref>
<xref ref-type="aff" rid="Aff2"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Mengmeng</given-names>
</name>
<xref ref-type="aff" rid="Aff1"></xref>
<xref ref-type="aff" rid="Aff2"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Qiu</surname>
<given-names>Zilong</given-names>
</name>
<xref ref-type="aff" rid="Aff3"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hu</surname>
<given-names>Keping</given-names>
</name>
<xref ref-type="aff" rid="Aff4"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McGee</surname>
<given-names>Warren</given-names>
</name>
<xref ref-type="aff" rid="Aff5"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Xiaoping</given-names>
</name>
<xref ref-type="aff" rid="Aff5"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Jianghong</given-names>
</name>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zhu</surname>
<given-names>Li</given-names>
</name>
<address>
<email>zhuli@moon.ibp.ac.cn</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Wu</surname>
<given-names>Jane Y.</given-names>
</name>
<address>
<email>jane-wu@northwestern.edu</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
<xref ref-type="aff" rid="Aff5"></xref>
</contrib>
<aff id="Aff1"><label></label>State Key Laboratory for Brain &amp; Cognitive Science, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101 China </aff>
<aff id="Aff2"><label></label>University of Chinese Academy of Sciences, Beijing, 100049 China </aff>
<aff id="Aff3"><label></label>Laboratory of Molecular Basis of Neural Plasticity, Institute of Neuroscience, Chinese Academy of Sciences, Shanghai, 200031 China </aff>
<aff id="Aff4"><label></label>Institute of Medicinal Plant Development (IMPLAD), Chinese Academy of Medical Sciences, Beijing, 100193 China </aff>
<aff id="Aff5"><label></label>Department of Neurology, Center for Genetic Medicine, Lurie Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL 60611 USA </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>1</day>
<month>6</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>1</day>
<month>6</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>7</month>
<year>2016</year>
</pub-date>
<volume>7</volume>
<issue>7</issue>
<fpage>489</fpage>
<lpage>500</lpage>
<history>
<date date-type="received">
<day>20</day>
<month>3</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>13</day>
<month>4</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2016</copyright-statement>
<license license-type="OpenAccess">
<license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p>MicroRNAs (miRNAs) are critical for both development and function of the central nervous system. Significant evidence suggests that abnormal expression of miRNAs is associated with neurodevelopmental disorders. MeCP2 protein is an epigenetic regulator repressing or activating gene transcription by binding to methylated DNA. Both loss-of-function and gain-of-function mutations in the <italic>MECP2</italic> gene lead to neurodevelopmental disorders such as Rett syndrome, autism and <italic>MECP2</italic> duplication syndrome. In this study, we demonstrate that miR-130a inhibits neurite outgrowth and reduces dendritic spine density as well as dendritic complexity. Bioinformatics analyses, cell cultures and biochemical experiments indicate that miR-130a targets <italic>MECP2</italic> and down-regulates MeCP2 protein expression. Furthermore, expression of the wild-type MeCP2, but not a loss-of-function mutant, rescues the miR-130a-induced phenotype. Our study uncovers the <italic>MECP2</italic> gene as a previous unknown target for miR-130a, supporting that miR-130a may play a role in neurodevelopment by regulating MeCP2. Together with data from other groups, our work suggests that a feedback regulatory mechanism involving both miR-130a and MeCP2 may serve to ensure their appropriate expression and function in neural development.</p>
<sec>
<title>Electronic supplementary material</title>
<p>The online version of this article (doi:10.1007/s13238-016-0272-7) contains supplementary material, which is available to authorized users.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>miR-130a</kwd>
<kwd>MECP2</kwd>
<kwd>neurite outgrowth</kwd>
<kwd>dendritic spines</kwd>
<kwd>dendrite morphology</kwd>
</kwd-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© HEP and Springer 2016</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1" sec-type="introduction">
<title>INTRODUCTION</title>
<p>MicroRNAs (miRNAs) are small non-coding RNAs of 16–28 nucleotides (nt) in lengths. They are transcribed into pri-miRNA, which are then cleaved by Drosha to form pre-miRNA in the nucleus. After being transported to the cytoplasm and then cleaved by Dicer, mature miRNAs incorporate with AGO proteins to form RNA-induced silencing complexes (RISCs) to silence target mRNAs (Finnegan and Pasquinelli, <xref ref-type="bibr" rid="CR18">2013</xref>). MicroRNAs play important roles in the formation and the function of the nervous system (McNeill and Van Vactor, <xref ref-type="bibr" rid="CR43">2012</xref>). Aberrant expression of miRNAs may lead to neurodevelopmental and neurodegenerative diseases (Im and Kenny, <xref ref-type="bibr" rid="CR29">2012</xref>). We identified microRNA-130a (miR-130a) in a search for microRNAs regulated by the Tar-DNA binding protein-43 (TDP-43) (The detail will be described in a separate paper). It has been reported that miR-130a regulates neurogenesis by inhibiting the synthesis of substance P (Greco and Rameshwar, <xref ref-type="bibr" rid="CR22">2007</xref>), a neuropeptide that can increase neurite outgrowth of cultured chick dorsal root ganglia (Shigehiko and Takeshi, <xref ref-type="bibr" rid="CR58">1978</xref>). In <italic>Xenopus laevis</italic>, miR-130a is expressed in anterior neural tissues, eyes and branchial arches (Walker and Harland, <xref ref-type="bibr" rid="CR68">2008</xref>), and down-regulation of miR-130a led to smaller eyes (Gessert et al., <xref ref-type="bibr" rid="CR21">2010</xref>). In mice, miR-130a is expressed in developing somites, neural tube and restricted regions of the brain after embryonic day 9.5 (Hoesel et al., <xref ref-type="bibr" rid="CR27">2010</xref>). Cerebral expression of miR-130a then decreases during the postnatal period throughout the rest of development and is detected only at a low level in the adult mouse cortex (Eda et al., <xref ref-type="bibr" rid="CR15">2011</xref>; Søe et al., <xref ref-type="bibr" rid="CR59">2011</xref>). Several studies suggest that dysregulation of miR-130a may be associated with neurodevelopmental disorders. For example, the expression of miR-130a is up-regulated in the serum of children with autism (Vasu et al., <xref ref-type="bibr" rid="CR66">2014</xref>). Analyses of the copy number variation (CNV) of miR-130a have led to the identification of 2 patients diagnosed with autism spectrum disorder carrying duplications of the locus (11q12.1) containing miR-130a (Rosenfeld et al., <xref ref-type="bibr" rid="CR52">2010</xref>). These reports suggest a potential role for miR-130a in neural development. However, the target genes and mechanisms by which miR-130a functions in neurons remain to be investigated.</p>
<p><italic>MECP2</italic> (Methyl-CpG-binding Protein 2) is an X-linked gene, encoding a methylated DNA-binding protein and has been identified as a causative gene in Rett syndrome (Amir et al., <xref ref-type="bibr" rid="CR2">1999</xref>; Lewis et al., <xref ref-type="bibr" rid="CR38">1992</xref>; reviewed in Lombardi et al., <xref ref-type="bibr" rid="CR40">2015</xref>). The MeCP2 protein has multiple biological functions, including regulating RNA transcription, involving in RNA splicing and miRNA biogenesis (Chahrour et al., <xref ref-type="bibr" rid="CR6">2008</xref>; Cheng et al., <xref ref-type="bibr" rid="CR10">2014</xref>; Maunakea et al., <xref ref-type="bibr" rid="CR41">2013</xref>; Nan et al., <xref ref-type="bibr" rid="CR46">1998</xref>; Young et al., <xref ref-type="bibr" rid="CR75">2005</xref>; Lombardi et al., <xref ref-type="bibr" rid="CR40">2015</xref>). Loss and gain of function mutations of MeCP2 lead to Rett syndrome and <italic>MECP2</italic> duplication syndrome, both of which are progressive neurological disorders characterized by intellectual disability, autism and developmental regression (Lombardi et al., <xref ref-type="bibr" rid="CR40">2015</xref>). Postmortem brain pathology analyses, MeCP2 mouse models and <italic>in vitro</italic> experiments suggest that MeCP2 regulates axon outgrowth, dendritic spine formation and dendritic arbor complexity (Chao et al., <xref ref-type="bibr" rid="CR7">2007</xref>; Chapleau et al., <xref ref-type="bibr" rid="CR8">2009</xref>; Cheng et al., <xref ref-type="bibr" rid="CR10">2014</xref>; Jiang et al., <xref ref-type="bibr" rid="CR30">2013</xref>; Jugloff et al., <xref ref-type="bibr" rid="CR32">2005</xref>; Lombardi et al., <xref ref-type="bibr" rid="CR40">2015</xref>). Neuronal expression of MeCP2 at an appropriate level is crucial for neural development. However, the mechanisms by which how MeCP2 is regulated remain to be elucidated.</p>
<p>The mammalian <italic>MECP2</italic> gene has a highly conserved long 3′ untranslated region (3′UTR) which contains multiple binding sites for microRNAs (Coy et al., <xref ref-type="bibr" rid="CR12">1999</xref>; McGowan and Pang, <xref ref-type="bibr" rid="CR42">2015</xref>). It was proposed that microRNAs binding to the 3′UTR of <italic>MECP2</italic> and regulating its expression might contribute to neuronal maturation and neurodevelopmental diseases (Hansen et al., <xref ref-type="bibr" rid="CR24">2010</xref>). In the present study, we examined the interaction between miR-130a and MeCP2. Our data demonstrate that miR-130a inhibits neurite outgrowth and dendritic spine formation by regulating MeCP2.</p>
</sec>
<sec id="Sec2" sec-type="results">
<title>RESULTS</title>
<sec id="Sec3">
<title>MiR-130a is expressed in developing cerebral cortex and is predicted to regulate neuronal function</title>
<p>The mature sequence of miR-130a is conserved across various species including mammals, birds, amphibians and fish (Fig. S1). To study the function of miR-130a in neurodevelopment, we first examined the expression of miR-130a in developing rat brains. Primary and mature rno-miR-130a were detected in the rat cerebral cortices at both embryonic (E18) and postnatal (P1) stages (Fig. <xref ref-type="fig" rid="Fig1">1</xref>), which is consistent with previous results in mice (Hoesel et al., <xref ref-type="bibr" rid="CR27">2010</xref>). There were no dramatic changes of the level of miR-130a between the late embryonic and early postnatal stages.<fig id="Fig1"><label>Figure 1</label><caption><p>
<bold>Expression of miR-130a in embryonic and postnatal rat brains</bold>. Rat cortical neurons were harvested from brains at the stages of E18 and P1. The levels of mature miR-130a (with U6 as an internal control) (upper panel) and primary miR-130a (with GAPDH as an internal control) (lower panel) were detected by RT-PCR. The last lane in each panel contained the negative control (NC) in which reverse transcriptase was omitted from the cDNA synthesis reactions</p></caption><graphic id="MO1" xlink:href="13238_2016_272_Fig1_HTML"></graphic></fig></p>
<p>To begin to explore biological function of miR-130a, we employed a bioinformatics approach using three miRNA target prediction tools—TargetScan, miRanda and PicTar—to predict candidate target genes for miR-130a (Agarwal et al., <xref ref-type="bibr" rid="CR1">2015</xref>; Krek et al., <xref ref-type="bibr" rid="CR34">2005</xref>; Betel et al., <xref ref-type="bibr" rid="CR5">2008</xref>). The pathway enrichment analysis (KOBAS 2.0; Xie et al., <xref ref-type="bibr" rid="CR73">2011</xref>) revealed potential target genes involved in multiple pathways important for neuronal function, such as axon guidance, synaptic vesicle formation and axonal transport. A number of the predicted miR-130a target genes are also associated with neurodevelopmental disorders, such as autism, schizophrenia and hereditary spastic paraplegia (Table <xref ref-type="table" rid="Tab1">1</xref>). These results, together with its expression in brain tissues, suggest that miR-130a may play an important role in regulating expression of genes crucial for the function of the nervous system.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Candidate target protein-coding genes for miR-130a</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="2">Diseases and pathways</th><th align="left">Database</th><th align="left">MiR-130a target genes</th><th align="left">Gene set size</th><th align="left">
<italic>P</italic>-value</th></tr></thead><tbody><tr><td align="left" rowspan="4">Neuronal function</td><td align="left">Axon guidance</td><td align="left">KEGG PATHWAY</td><td align="char" char=".">9</td><td align="char" char=".">129</td><td align="char" char=".">0.0102891</td></tr><tr><td align="left">Synaptic vesicle formation</td><td align="left">KEGG PATHWAY</td><td align="char" char=".">5</td><td align="char" char=".">63</td><td align="char" char=".">0.0321619</td></tr><tr><td align="left">Lissencephaly gene (LIS1) in neuronal migration and development</td><td align="left">PID</td><td align="char" char=".">3</td><td align="char" char=".">19</td><td align="char" char=".">0.0403738</td></tr><tr><td align="left">SNARE interactions in vesicular transport</td><td align="left">KEGG PATHWAY</td><td align="char" char=".">3</td><td align="char" char=".">36</td><td align="char" char=".">0.0807329</td></tr><tr><td align="left" rowspan="8">Nervous system disorders</td><td align="left">Hereditary spastic paraplegia (SPG)</td><td align="left">KEGG DISEASE</td><td align="char" char=".">4</td><td align="char" char=".">21</td><td align="char" char=".">0.0058905</td></tr><tr><td align="left">Autistic spectrum disorder</td><td align="left">FunDO</td><td align="char" char=".">6</td><td align="char" char=".">68</td><td align="char" char=".">0.013854</td></tr><tr><td align="left">Schizophrenia</td><td align="left">FunDO</td><td align="char" char=".">10</td><td align="char" char=".">172</td><td align="char" char=".">0.0239614</td></tr><tr><td align="left">Lissencephaly</td><td align="left">KEGG DISEASE</td><td align="char" char=".">2</td><td align="char" char=".">6</td><td align="char" char=".">0.0218963</td></tr><tr><td align="left">Non-syndromic X-linked mental retardation</td><td align="left">KEGG DISEASE</td><td align="char" char=".">3</td><td align="char" char=".">22</td><td align="char" char=".">0.0368521</td></tr><tr><td align="left">Congenital disorders of development</td><td align="left">KEGG DISEASE</td><td align="char" char=".">13</td><td align="char" char=".">244</td><td align="char" char=".">0.0426269</td></tr><tr><td align="left">Isolated orofacial clefts</td><td align="left">KEGG DISEASE</td><td align="char" char=".">2</td><td align="char" char=".">14</td><td align="char" char=".">0.0803631</td></tr><tr><td align="left">Spinocerebellar ataxias</td><td align="left">FunDO</td><td align="char" char=".">2</td><td align="char" char=".">12</td><td align="char" char=".">0.0520478</td></tr></tbody></table><table-wrap-foot><p>Target genes for miR-130a were predicted using TargetScan, miRanda and PicTar. The intersection of the results from all three tools was accepted as the potential targets. A total of 475 potential target genes were identified by the bioinformatics analyses (see <xref ref-type="sec" rid="Sec10">MATERIALS AND METHODS</xref>). Shown in the table are the pathways most enriched with protein-coding genes predicted to be targets of miR-130a (“MiR-130a target genes” column) and corresponding raw <italic>P</italic>-values. The “Gene set size” is determined based on the protein coding genes in the genome that have been annotated with the specific pathways by the respective database.</p></table-wrap-foot></table-wrap></p>
</sec>
<sec id="Sec4">
<title>MiR-130a inhibits neurite outgrowth</title>
<p>Neuronal differentiation is an early and fundamental event in neurodevelopment. The sprouting and outgrowth of neurites followed by the formation of axons and dendrites is an initial critical process in the early stage of development of the nervous system (Lefebvre, Sanes and Kay, <xref ref-type="bibr" rid="CR37">2015</xref>; Takano et al., <xref ref-type="bibr" rid="CR62">2015</xref> and references within). To investigate the role of miR-130a in neuronal development, we examined the effect of miR-130a on neurite outgrowth using primary rat neuronal cultures. Cortical neurons were transfected with a control vector or a plasmid expressing pri-miR-130a that also expressed GFP to mark transfected neurons. Seventy-two hours following transfection, the neurite length was measured by tracing the longest neurite of randomly-selected transfected neurons and quantified using Image J, as published previously (Gao et al., <xref ref-type="bibr" rid="CR20">2010</xref> and reference within). Neurons transfected with miR-130a showed shorter neurite length, approximately 65% of that in the control neurons (Fig. <xref ref-type="fig" rid="Fig2">2</xref>A and <xref ref-type="fig" rid="Fig2">2</xref>C). To confirm the effect of miR-130a on neurite outgrowth, a specific RNA inhibitor for miR-130a was used. Rat primary cortical neurons were transfected with a scrambled RNA control or the miR-130a inhibitor together with a plasmid expressing GFP. Neurons transfected with the miR-130a inhibitor showed greater neurite length, approximately 150% of that in neurons transfected with the control scrambled RNA (Fig. <xref ref-type="fig" rid="Fig2">2</xref>B and <xref ref-type="fig" rid="Fig2">2</xref>C). This effect of miR-130a on the neurite length was not due to its effect on neuronal survival, because miR-130a did not affect neuronal death as shown by a Terminal deoxyribonucleotidyl transferase-mediated dUTP-digoxigenin nick end labeling (TUNEL) assay and nuclear staining (Fig. S2). We also examined whether miR-130 affected the number of neurite branches per neuron (Fig. S3A). Quantitative analyses of distribution of neurite branch numbers did not show any significant difference between the control and miR-130a groups, indicating that neurite numbers were not affected by miR-130a (Fig. S3B).<fig id="Fig2"><label>Figure 2</label><caption><p>
<bold>MiR-130a decreases the length of neurites in cultured primary cortical neurons</bold>. (A) Cortical neurons isolated from E18 rat embryos were electroporated with the vector control (Ctr; upper panels A1–A4) or the miR-130a expression plasmid (lower panels a1–a4) and cultured for 3 days. Representative images of neurons are shown from either control or miR-130a groups to illustrate the range of neurite outgrowth. Scale bar: 25 μm. (B) Cortical neurons from E18 embryos were electroporated with the scrambled RNA control (Scr; upper panels B1–B4) or the miR-130a inhibitor (MiR-130a-inh; lower panels b1–b4) and cultured for 3 days. Representative images of neurons are shown for the corresponding groups to illustrate the range of neurite outgrowth. Scale bar: 25 μm. (C) Quantification of the average lengths of the longest neurites (mean values ± SEM) in experiments shown in panels (A) and (B). At least 100 neurons in each group were randomly selected and scored in each experiment. ***, <italic>P</italic> &lt; 0.001, Mann-Whitney test. Data represent three independent experiments</p></caption><graphic id="MO2" xlink:href="13238_2016_272_Fig2_HTML"></graphic></fig></p>
</sec>
<sec id="Sec5">
<title>MiR-130a expression decreases dendritic complexity</title>
<p>Dendritic formation and maturation is critical for the formation and maintenance of the nervous system. To study the effect of miR-130a on dendrite formation, rat E18 primary cortical neurons were cultured for 7 days and then transfected with the control or miR-130a, and then fixed at DIV18 for examining dendritic morphology. The dendrites were traced and analyzed using NeuronJ (ImageJ) and NeuronStudio with neuronal morphology quantified using Sholl analysis as described previously (Kutzing et al., <xref ref-type="bibr" rid="CR35">2010</xref>; Langhammer et al., <xref ref-type="bibr" rid="CR36">2010</xref>). Dendritic complexity was decreased in miR-130a transfected neurons as compared with the control neurons, including the number of branch points and terminal points per neuron, as well as the number of intersections (Fig. <xref ref-type="fig" rid="Fig3">3</xref>A–C). Further analyses revealed that miR-130a decreased the number of secondary and tertiary branches, but did not affect primary branches (Fig. <xref ref-type="fig" rid="Fig3">3</xref>D and <xref ref-type="fig" rid="Fig3">3</xref>E). The lack of effect on primary branches by miR-130a is consistent with what was observed with the number of neurites (Fig. S3). In addition, the total length of dendrites was decreased in miR-130a expressing neurons as compared with the control group, although the average length of segments did not change (Fig. <xref ref-type="fig" rid="Fig3">3</xref>F and <xref ref-type="fig" rid="Fig3">3</xref>G). These data together show that miR-130a expression reduces dendritic complexity, in particular, inhibits the formation of the secondary and tertiary branches.<fig id="Fig3"><label>Figure 3</label><caption><p>
<bold>MiR-130a decreases the complexity of dendrites</bold>. (A) Cortical neurons were cultured for 7 days and transfected with control or miR-130a. Cells were fixed at 18 DIV. Images were taken using Leica confocal SP8. Image of 40× microscopy were demonstrated. Scale bar: 25 μm. (B) The number of branch points and terminal points per cell. (C) The Sholl analysis of dendritic complexity as measured by number of intersections. (D) The Sholl analysis of dendritic complexity by branch order-primary, secondary and tertiary branches. (E) The number of segments in total and by branch order. (F) Average length of segments per cell. (G) The total length of branches per cell. **, <italic>P</italic> &lt; 0.01; ***, <italic>P</italic> &lt; 0.001, Mann-Whitney test. Fifteen neurons were scored in each group in each experiment. The bar diagram represents mean values ± SEM. Data represent 3 independent experiments</p></caption><graphic id="MO3" xlink:href="13238_2016_272_Fig3_HTML"></graphic></fig></p>
</sec>
<sec id="Sec6">
<title><italic>MECP2</italic> is a target of miR-130a</title>
<p>To investigate mechanism of miR-130a function, we sought to identify candidate target genes for miR-130a. Among the potential target gene pathways predicted by our bioinformatics analyses (Table <xref ref-type="table" rid="Tab1">1</xref>), we decided to first examine candidate genes involved in neurodevelopment and associated with neurodevelopmental diseases. <italic>MECP2</italic> is one of these predicted target genes for miR-130a. The human <italic>MECP2</italic> gene has a long conserved 3′UTR (~8 kb) with containing 4 predicted miR-130a binding sites. The most upstream miR-130a binding site located ~240 nucleotide downstream of the stop codon is highly conserved, from human to rodents (Fig. <xref ref-type="fig" rid="Fig4">4</xref>A). To validate that <italic>MECP2</italic> is a target gene of miR-130a, a dual luciferase reporter assay in HEK293 cells was performed. A luciferase reporter plasmid was constructed containing a 415-bp fragment of the 3′UTR of the human <italic>MECP2</italic> gene including the most highly conserved miR-130a binding site (the most upstream binding site in the 3′UTR; Fig. <xref ref-type="fig" rid="Fig4">4</xref>A). When co-transfected with miR-130a, luciferase activity of the <italic>MECP2</italic> 3′UTR reporter was significantly reduced, whereas mutating the predicted miR-130a binding site in the <italic>MECP2</italic> reporter (3′UTRmt) reversed the miR-130a inhibition, indicating that the 3′UTR of the human <italic>MECP2</italic> gene is responsive to miR-130a expression (Fig. <xref ref-type="fig" rid="Fig4">4</xref>B). The mRNA and protein levels of MeCP2 were examined following transfection of pri-miR-130a or miR-130a inhibitor. Western blotting of transfected rat cortical neurons showed expression of miR-130a decreased MeCP2 protein expression to ~40% of that in the control group, whereas the expression of the miR-130a inhibitor increased the MeCP2 protein level to ~3 fold of that in the scramble control group (Fig. <xref ref-type="fig" rid="Fig4">4</xref>C and <xref ref-type="fig" rid="Fig4">4</xref>E). RT-PCR assays showed that expression of neither miR-130a nor miR-130a inhibitor altered the mRNA levels of MeCP2 (Fig. <xref ref-type="fig" rid="Fig4">4</xref>D and <xref ref-type="fig" rid="Fig4">4</xref>F). Because miRNAs may regulate protein expression by translational inhibition or mRNA degradation or both mechanisms (Hausser and Zavolan, <xref ref-type="bibr" rid="CR25">2014</xref>; Vidigal and Ventura, <xref ref-type="bibr" rid="CR67">2015</xref>; Wilczynska and Bushell, <xref ref-type="bibr" rid="CR71">2015</xref>), these results suggest that miR-130a may decrease the MeCP2 protein level by affecting translation efficiency rather than degrading MeCP2 mRNA. Future studies are necessary to elucidate the precise mechanisms by which miR-130a regulates MeCP2 protein production.<fig id="Fig4"><label>Figure 4</label><caption><p>
<bold>The</bold>
<bold><italic>MECP2</italic></bold>
<bold>gene is a target of miR-130a</bold>. (A) Alignment of the binding sites of miR-130a on MECP2 mRNA 3′UTR. The seed regions of miR-130a binding sites are in italics. Luciferase reporter plasmids containing the human MECP2-3′UTR regions, either the wild type UTR (MECP2-3′UTR) or the mutant UTR with the most highly conserved binding site for miR-130a mutated as shown (MECP2-3′UTR mutant). (B) A dual luciferase reporter assay. Relative luciferase activity was measured in HEK293 cells at 48 h post-transfection. The wild-type MECP2-3′UTR is referred to as “3′UTR”, whereas the mutant described in panel (A) is indicated as “3′UTRmt”. (C) The MeCP2 protein levels as detected by Western blotting. Rat E18 cortical neurons were electroporated with the control vector, miR-130a, scramble RNA (Scr) or miR-130a inhibitor (miR-130a-inh). β-Tubulin was used as an internal control. (D) The MeCP2 mRNA levels as assayed by RT-PCR with β-tubulin as an internal control. (E and F) Quantification and statistical analysis of data in (C) and (D). The bar diagram represents mean values ± SEM. Data represent three independent experiments. *, <italic>P</italic> &lt; 0.05; **, <italic>P</italic> &lt; 0.01; ***, <italic>P</italic> &lt; 0.001. Mann-Whitney test</p></caption><graphic id="MO4" xlink:href="13238_2016_272_Fig4_HTML"></graphic></fig></p>
</sec>
<sec id="Sec7">
<title>Restoring MeCP2 expression rescues miR-130a-mediated inhibition of neurite outgrowth</title>
<p>It was reported that MeCP2 promotes axon outgrowth in mouse primary cortical neurons (Jugloff et al., <xref ref-type="bibr" rid="CR32">2005</xref>). The phosphorylation of MeCP2 at Ser80 is necessary for MeCP2 chromatin binding ability and neurological function (Tao et al., <xref ref-type="bibr" rid="CR63">2009</xref>). When the Ser80 was mutated to alanine (MeCP2<sup>S80A</sup>), the S80A-mutant MeCP2 protein cannot be phosphorylated, acting as a loss-of function mutant. We co-transfected the wild-type MeCP2 or MeCP2<sup>S80A</sup> together with miR-130a into cortical neurons and examined if MeCP2 could rescue the effect of miR-130a on the neurite outgrowth. The average neurite length was measured as described above. Neurons transfected with MeCP2 alone showed longer neurite length, approximately 2 fold of that of control neurons, whereas neurons transfected with MeCP2<sup>S80A</sup> mutant did not show any changes in the average neurite length (Fig. <xref ref-type="fig" rid="Fig5">5</xref>A and <xref ref-type="fig" rid="Fig5">5</xref>B). Expression of MeCP2 in miR-130a transfected neurons significantly increased neurite length, ~30% longer than that of neurons transfected with miR-130a alone. However, expression of the mutant form of MeCP2, MeCP2<sup>S80A</sup>, ablated this rescue effect. Our data show that miR-130a negatively regulates neurite length in part by down-regulating MeCP2.<fig id="Fig5"><label>Figure 5</label><caption><p>
<bold>Expression of miR-130a decreases the length of neurites, a phenotype partially rescued by wild type MeCP2 but not by a loss-of-function MeCP2 mutant</bold>. (A) Rat E18 cortical neurons were electroporated with the vector control, miR-130a, MeCP2, MeCP2<sup>S80A</sup> or miR-130a together with MeCP2 or MeCP2<sup>S80A</sup> and cultured for 3 days before imaging. Scale bar: 25 μm. (B) The average length of the longest neurites in (A) were measured and statistically analyzed from three independent experiments (mean values ± SEM; at least 100 neurons in each group were scored in each experiment). **, <italic>P</italic> &lt; 0.01; ***, <italic>P</italic> &lt; 0.001. Mann-Whitney test</p></caption><graphic id="MO5" xlink:href="13238_2016_272_Fig5_HTML"></graphic></fig></p>
</sec>
<sec id="Sec8">
<title>MiR-130a decreases dendritic spine density and MeCP2 rescues the miR-130a-induced phenotype</title>
<p>Dendritic spines are membrane protrusions on dendrites and play critical roles in the formation of synapses and neural circuits (Ethell and Pasquale, <xref ref-type="bibr" rid="CR16">2005</xref>). We examined the effect of miR-130a on dendritic spine formation. In this set of experiments, rat E18 primary cortical neurons were cultured for 21 days <italic>in vitro</italic> and then transfected using Lipofectamine with the control or with miR-130a. Cells were then fixed 3 days post-transfection. The density of dendritic spines on the secondary and tertiary dendritic branches was determined. Neurons transfected with miR-130a showed fewer dendritic spines as compared with the control neurons (Fig. <xref ref-type="fig" rid="Fig6">6</xref>A, panel a1 and a2). Both gain-of- and loss-of-function mutations of the <italic>MECP2</italic> gene lead to neurodevelopment disorders with dendritic spine morphological abnormalities, suggesting the proper level of functional MeCP2 is critical for neural development (Jiang et al., <xref ref-type="bibr" rid="CR30">2013</xref>; Xu et al., <xref ref-type="bibr" rid="CR74">2014</xref>). Indeed, overexpression of MeCP2 alone reduced dendritic spine density (Fig. <xref ref-type="fig" rid="Fig6">6</xref>A, panel a5), consistent with previous data from hippocampal slice cultures (Xu et al., <xref ref-type="bibr" rid="CR74">2014</xref>).<fig id="Fig6"><label>Figure 6</label><caption><p>
<bold>Expression of miR-130a decreased the density of dendritic spines, a phenotype that can be rescued by functional MeCP2 but not by MeCP2 mutant</bold>. (A) Rat E18 cortical neurons were cultured for 21 days and then transfected with vector control, miR-130a, MeCP2, MeCP2<sup>S80A</sup> or miR-130a mixed with MeCP2 or MeCP2<sup>S80A</sup>. Upper panels (A1–A6): image of 20× microscopy demonstrated the healthy morphology of neurons. The boxed areas by dotted lines in the top panels are enlarged and shown in lower panels and used for quantification of the secondary and tertiary dendrites. Scale bar: 75 μm. Lower panels (a1–a6): high magnifications of image (100× lens; zoom 4.0×) demonstrated the morphology of dendritic spines. Scale bar: 2.5 μm. (B) The average density of dendritic spines. Spines on the secondary and tertiary dendrites were measured. The bar diagram represents mean values ± SEM. Data represent three independent experiments (Ten neurons were scored in each experiment). **, <italic>P</italic> &lt; 0.01; ***, <italic>P</italic> &lt; 0.001, Mann-Whitney test</p></caption><graphic id="MO6" xlink:href="13238_2016_272_Fig6_HTML"></graphic></fig></p>
<p>We then asked whether the phenotype of decreased spine density by miR-130a was mediated by regulating MeCP2. Neurons co-expressing miR-130a and MeCP2 showed a partial rescue effect, with a higher density than neurons transfected with either miR-130a or MeCP2 alone (Fig. <xref ref-type="fig" rid="Fig6">6</xref>A, panel a3). This rescue effect was not observed when S80A mutant MeCP2 was co-transfected with miR-130a (Fig. <xref ref-type="fig" rid="Fig6">6</xref>A, panel a4). Taken together, our data suggest that miR-130a decreases dendritic spine density in part by regulating MeCP2.</p>
</sec>
</sec>
<sec id="Sec9" sec-type="discussion">
<title>DISCUSSION</title>
<p>In this study we sought to determine the role of miR-130a in neuronal development, and examined whether effects of miR-130a were mediated by regulating <italic>MECP2</italic> gene expression. Consistent with previous studies carried out in mice (Hoesel et al., <xref ref-type="bibr" rid="CR27">2010</xref>; Eda et al., <xref ref-type="bibr" rid="CR15">2011</xref>; Søe et al., <xref ref-type="bibr" rid="CR59">2011</xref>), miR-130a is expressed in rat cortical neurons at the late embryonic and early postnatal stages (Fig. <xref ref-type="fig" rid="Fig1">1</xref>). Bioinformatics analyses suggest that miR-130a may be involved in neurogenesis and associated with neurodevelopmental disorders such as schizophrenia, lissencephaly and autism (Table <xref ref-type="table" rid="Tab1">1</xref>) (Poluch and Juliano, <xref ref-type="bibr" rid="CR50">2015</xref>; Selemon and Zecevic, <xref ref-type="bibr" rid="CR55">2015</xref>; Wang and Baraban, <xref ref-type="bibr" rid="CR69">2007</xref>; Wegiel et al., <xref ref-type="bibr" rid="CR70">2010</xref>). Neurogenesis is not only essential for the formation of the nervous system during development, but also critical for the maintenance and neural repair in the adult brain (Feliciano et al., <xref ref-type="bibr" rid="CR17">2015</xref>; Zhao et al., <xref ref-type="bibr" rid="CR76">2008</xref>). Defects in neurogenesis are associated with a large number of neurological disorders, including neurodevelopmental diseases and neurodegenerative disorders such as Alzheimer’s Disease and Parkinson’s Disease (Merson and Bourne, <xref ref-type="bibr" rid="CR44">2014</xref>; Schoenfeld and Cameron, <xref ref-type="bibr" rid="CR54">2015</xref>; Winner and Winkler, <xref ref-type="bibr" rid="CR72">2015</xref>).</p>
<p>Our bioinformatics analyses suggest that miR-130a may be involved in many pathways critical for neurodevelopment and associated with pathogenesis of neurodevelopmental diseases (Table <xref ref-type="table" rid="Tab1">1</xref>). Using primary neuronal cultures, we provided experimental evidence that miR-130a plays a role in regulating both neurite outgrowth and dendritic formation. The outgrowth of neurites, which will differentiate into axons and dendrites, is an important event in neural development (Takano et al., <xref ref-type="bibr" rid="CR62">2015</xref>; Lefebvre, Sanes, Kay <xref ref-type="bibr" rid="CR37">2015</xref>). MiR-130a expression reduces neurite outgrowth, whereas miR-130a inhibitor increases neurite outgrowth (Fig. <xref ref-type="fig" rid="Fig2">2</xref>). Expression of miR-130a also reduces dendritic complexity without affecting the number of primary dendritic branches (Fig. <xref ref-type="fig" rid="Fig3">3</xref>). Finally, miR-130a reduces the density of dendritic spines (Fig. <xref ref-type="fig" rid="Fig6">6</xref>). Overall, these results suggest that miR-130a may play a complex role in regulating neurogenesis and neuronal differentiation. The expression of miR-130a was reported to be decreased in the cerebral cortex of mouse brain but increased in hippocampus from birth to adulthood (Eda et al., <xref ref-type="bibr" rid="CR15">2011</xref>). This dynamic expression pattern of miR-130a suggests that the function of miR-130a in the nervous system may be different depending on the specific regions and developmental stages. It should be noted that it has been observed that the expression of a number of miRNAs was affected in MeCP2-deficient mice, including the down-regulation of miR-130a (Urdinguio et al., <xref ref-type="bibr" rid="CR64">2010</xref>). Together with our data, these results suggest that miR-130a together with MeCP2 may participate in a feedback regulatory loop that maintain the appropriate levels of both miR-130a and MeCP2 to ensure their proper function of neural development in a spatially and temporally regulated manner. It is obvious that further studies are necessary for elucidating the role of miR-130a in neurodevelopment.</p>
<p>Our data support that miR-130a inhibits neurite outgrowth, at least in part, by regulating <italic>MECP2</italic>, a predicted target gene by three bioinformatics tools. MiR-130a expression decreased the protein level of MeCP2 but did not affect its mRNA level (Fig. <xref ref-type="fig" rid="Fig4">4</xref>). This can be explained by the possible activity of miR-130a in regulating translation efficiency rather than mRNA stability, a mechanism that has been described for a subset of miRNAs (Baek et al., <xref ref-type="bibr" rid="CR3">2008</xref>). The human <italic>MECP2</italic> gene has at least 4 transcripts of different lengths, among which the 10 kb mRNA contains the longest 3′UTR (~8 kb). This transcript is predominantly expressed in the brain, whereas the short transcripts are mainly expressed in the lung and liver (Pelka et al., <xref ref-type="bibr" rid="CR47">2005</xref>). Only the longest 3′UTR contains multiple miR-130a binding sites in different species. In addition, the 3′UTR of <italic>MECP2</italic> is highly conserved in both sequence and RNA secondary structure (Coy et al., <xref ref-type="bibr" rid="CR12">1999</xref>). These all suggest that miR-130a may regulate MeCP2 in a conserved manner and the regulation may be relatively specific to the nervous system. Variants in the <italic>MECP2 </italic> 3′UTR were found among patients affected by autism and Rett syndrome, although none of the variants is predicted to be pathogenic to Rett syndrome (Santos et al., <xref ref-type="bibr" rid="CR53">2008</xref>; Shibayama et al., <xref ref-type="bibr" rid="CR57">2004</xref>). However, MeCP2 mRNA levels in four autism patients carrying conserved 3′UTR alterations were lower (Coutinho et al., <xref ref-type="bibr" rid="CR11">2007</xref>). These findings suggest that mutations in the 3′UTR might impact the expression of MeCP2 (McGowan and Pang, <xref ref-type="bibr" rid="CR42">2015</xref>).</p>
<p>It has been reported previously that DNA methylation and histone modification are important to neurite outgrowth in PC12 cells (Futamura et al., <xref ref-type="bibr" rid="CR19">1995</xref>; Persengiev and Kilpatrick, <xref ref-type="bibr" rid="CR48">1996</xref>). MeCP2 is a methylated DNA binding protein regulating gene transcription, playing important roles in histone deacetylation and chromatin remodeling by recruiting histone deacetylase (Chahrour et al., <xref ref-type="bibr" rid="CR6">2008</xref>; Jones et al., <xref ref-type="bibr" rid="CR31">1998</xref>; Nan et al., <xref ref-type="bibr" rid="CR46">1998</xref>). MeCP2 was reported to promote axon outgrowth in mouse cortical neurons, and the suppression of MeCP2 in PC12 cells inhibited the neurite extension (Cusack et al., <xref ref-type="bibr" rid="CR13">2004</xref>; Jugloff et al., <xref ref-type="bibr" rid="CR32">2005</xref>). MeCP2<sup>S80A</sup> could not be phosphorylated and lacked the chromatin binding ability (Tao et al., <xref ref-type="bibr" rid="CR63">2009</xref>). In addition, it was found that S80-phosphorylated MeCP2 could suppress nuclear miRNA processing by binding Drosha, the initial processing complex for generating pre-miRNAs, and regulate Drosha function in an activity-dependent manner (Cheng et al., <xref ref-type="bibr" rid="CR10">2014</xref>). In our study, the wild type MeCP2 promoted neurite outgrowth and effectively rescued the phenotype induced by miR-130a, whereas MeCP2<sup>S80A</sup> lost this activity (Fig. <xref ref-type="fig" rid="Fig5">5</xref>). Because MeCP2 also regulates microRNA biogenesis, including that of miR-130a (Urdinguio et al., <xref ref-type="bibr" rid="CR64">2010</xref>), it might be difficult to interpret complex results if the rescue experiments were performed in MeCP2-null background. These results suggest that miR-130a inhibits neurite outgrowth by targeting MeCP2, and that MeCP2 may affect neurite outgrowth via its activity in regulating chromatin structure and/or modulating miRNA processing. Much more work is necessary to further understand the underlying mechanisms, especially the reciprocal relationship between MeCP2 and miR-130a.</p>
<p>Reduced dendritic spine density is a common feature in individuals with Rett syndrome (Phillips and Pozzo-Miller, <xref ref-type="bibr" rid="CR49">2015</xref>; Xu et al., <xref ref-type="bibr" rid="CR74">2014</xref>), knockdown of the endogenous MeCP2 also reduced dendritic spine density (Chapleau et al., <xref ref-type="bibr" rid="CR8">2009</xref>). Consistent with this, expression of MeCP2 rescued the decreased spine density caused by miR-130a. It has been reported that dendritic spine density in terminal dendritic branches of young transgenic mice expressing MeCP2 (a <italic>MECP2</italic> duplication syndrome mouse model) was initially higher than the control group and then decreased after postnatal week 12 (Jiang et al., <xref ref-type="bibr" rid="CR30">2013</xref>). The dendrite outgrowth phenotype in the MeCP2 overexpressing mice during the early stage (See Fig. <xref ref-type="fig" rid="Fig1">1</xref> of Jiang et al., <xref ref-type="bibr" rid="CR30">2013</xref>) is consistent with our observation. On the other hand, it has also been reported that expression of MeCP2 inhibited dendritic spine development in rat hippocampal slice cultures (Cheng et al., <xref ref-type="bibr" rid="CR10">2014</xref>). Data from different studies suggest that both MeCP2 overexpression and MeCP2 loss of function result in complex phenotypes in dendritic development (Na et al., <xref ref-type="bibr" rid="CR45">2013</xref>; Zhou et al., <xref ref-type="bibr" rid="CR77">2006</xref>; Jiang et al., <xref ref-type="bibr" rid="CR30">2013</xref>; Cheng et al., <xref ref-type="bibr" rid="CR10">2014</xref>). Therefore, the observation in our neuronal culture system that MeCP2 increased dendritic spine density in miR-130a expressing neurons may reflect a delicate balance and dynamic changes in the combinatorial effects of MeCP2 and microRNAs during dendritic development.</p>
<p>Neurons require proper homeostasis of MeCP2 to function normally (Lombardi et al., <xref ref-type="bibr" rid="CR40">2015</xref>). Loss of function of MeCP2 leads to severe neurodevelopmental diseases such as Rett syndrome, autism and schizophrenia; whereas the gain of function of MeCP2 may cause <italic>MECP2</italic> duplication syndrome (Lombardi et al., <xref ref-type="bibr" rid="CR40">2015</xref>; Van Esch, <xref ref-type="bibr" rid="CR65">2011</xref>). Phenotypes of Rett syndrome and <italic>MECP2</italic> duplication syndrome in mouse models can be reversed if MeCP2 level is properly restored (Robinson et al., <xref ref-type="bibr" rid="CR51">2012</xref>; Sztainberg et al., <xref ref-type="bibr" rid="CR61">2015</xref>). Taken together, our data support that miR-130a exhibits an inhibitory role on neurite outgrowth, dendritic branching and dendritic spine maturation, partially by targeting MeCP2. Seminal reviews on miRNAs have discussed about miRNAs as multi-facet regulators acting beyond simple repression of gene expression: buffering noise in the expression of their targets or setting a threshold-linear response (Bartel, <xref ref-type="bibr" rid="CR4">2009</xref>; Hausser and Zavolan, <xref ref-type="bibr" rid="CR25">2014</xref>). In this way, miR-130a could serve to buffer changes in MeCP2 protein expression and may help maintain MeCP2 at an appropriate level, which is essential for its function. Future studies are necessary to elucidate the complex mechanisms controlling all these events.</p>
</sec>
<sec id="Sec10" sec-type="materials|methods">
<title>MATERIALS AND METHODS</title>
<sec id="Sec11">
<title>Prediction of target genes for miR-130a by bioinformatics analyses</title>
<p>Target genes for miR-130a were predicted using TargetScan, miRanda and PicTar. The intersection of the results from all three tools was accepted as the potential targets. The Entrez Gene IDs of potential targets were downloaded from Ensembl and entered into KOBAS2.0 (with default setting) for annotation of gene pathways, disease associated genes and GeneOntology (GO) terms. The result of annotation was then used to identify statistically significantly enriched pathways, diseases and GO terms using protein-coding genes from the whole human genome set (20,192 genes) as background.</p>
</sec>
<sec id="Sec12">
<title>Cell culture and transfection</title>
<p>Embryonic day 18 (E18) rat cortical neurons were cultured and transfected following published protocols (Gao et al., <xref ref-type="bibr" rid="CR20">2010</xref>; Guo et al., <xref ref-type="bibr" rid="CR23">2011</xref>). Briefly, following electroporation (Amaxa Nucleofector II), neurons were seeded onto poly-D-lysine coated coverslips in 12-well plates. In the experiments for analyses of dendrite morphology and spine density, Lipofectamine2000 was used for transfecting neurons at 7 days and 21 days <italic>in vitro</italic> (DIV).</p>
</sec>
<sec id="Sec13">
<title>Plasmids and RNA inhibitors</title>
<p>MeCP2 and MeCP2<sup>S80A</sup> plasmids were as described previously (Cheng et al., <xref ref-type="bibr" rid="CR10">2014</xref>). MiR-130a plasmid was generated using pCDH-CMV-MCS-EF1-copGFP (CD511B-1, System Biosciences) according to the manufacturer’s instructions. MiR-130a genomic sequence was amplified with the following primers: forward, 5′-TGCTCTAGAGGTCATCTGAGAGTGTTGCCT-3′; reverse, 5′-CCGGGATCCTGACCCTCAGTTTTTCATCCA-3′. The miR-130a inhibitor was a methylation-modified RNA oligonucleotide complementary to miR-130a (GenePharma).</p>
</sec>
<sec id="Sec14">
<title>Luciferase reporter assay</title>
<p>Plasmids expressing wild-type or mutant human <italic>MECP2</italic> 3′UTR reporter genes containing a 415-bp fragment including the most conserved miR-130a binding site (shown as the “240 site” in Fig. <xref ref-type="fig" rid="Fig4">4</xref>A) were constructed using psiCHECK2 vector (Promega). The PCR amplification primers were as follows, wild-type MECP2-3′UTR primers: forward primer, 5′-CCGCTCGAGCGGAGCGGATTGCAAAGC-3′; and reverse primer, 5′-ATTTGCGGCCGCTGTAGACGGGGCACTGATGG-3′. The mutant forward primer is designed across the first miR-130a binding site, introducing a mutation that scrambles the entire seed region (underlined portion, see Fig. <xref ref-type="fig" rid="Fig4">4</xref>A): MECP2-3′UTR mutant primers: forward, 5′-GGCCAGAAGTAGCT<underline>AACGTGA</underline>TTTCTA AACTAGGCTC-3′; and reverse, 5′-GCCTAGTTTAGAAATCACGTTAGCTACTTCTGGCCC-3′. The positive control was the same vector inserted with the complementary sequence of miR-130a. Luciferase assay was performed using Dual-Luciferase® Reporter Assay System (Promega). MiR-130a and MECP2 3′UTR were co-transfected to HEK293 cells at the ratio of 36.5:1. 48 h following transfection, cells were lysed with the activity of Renilla luciferase measured according to the manufacturer’s instructions.</p>
</sec>
<sec id="Sec15">
<title>RNA extraction and RT-PCR</title>
<p>Total RNA was extracted using TriZol reagent (Invitrogen). Genomic DNA was removed with RNase-free DNase (NEB). Total cDNA was reverse-transcribed using SuperScript™ III Reverse Transcriptase (Invitrogen). PCR primers of MeCP2 are: forward, 5′-AGAGGAAGTCTGGTCGCTCT-3′, reverse, 5′-CCAGGCTTTCTACCCCGTTT-3′. Primary miR-130a: forward, 5′-AGGATGAGAGGAAGGCTGTG-3′, reverse, 5′-AGAAAACAGTGACGCTGAGG-3′; GAPDH: forward, 5′-CCCCCAATGTATCCGTTGTG-3′, reverse, 5′-TAGCCCAGGATGCCCTTTAGT-3′; U6: forward, 5′-CTCGCTTCGGCAGCACA-3′, reverse, 5′-AACGCTTCACGAATTTGCGT-3′.</p>
<p>RT-PCR detection of mature miR-130a was performed using poly(T) adaptor-PCR as described previously (Shi et al., <xref ref-type="bibr" rid="CR56">2012</xref>). Poly (T) adaptor: 5′-AAGCAGTGGTATCAACGCAGAGTGC(T)<sub>30</sub>VN-3′; poly(T) adaptor reverse primer: 5′-CTCACACGACTCACGACAGGGCAAGCAGTGGTATCAACGCAGAGTG-3′; miR-130a specific forward primer: 5′-TGCGGCAGTGCAATGTTAAAAGGGCAT-3′.</p>
</sec>
<sec id="Sec16">
<title>TUNEL assay</title>
<p>E18 rat cortical neurons were dissociated and electroporated with control vector or miR-130a plasmid. Cells were cultured for 3 days. Terminal deoxyribonucleotidyl transferase (TDT)-mediated dUTP-digoxigenin nick end labeling (TUNEL) was performed using In Situ Cell Death Detection Kit (Roche) as described in (Zhu et al., <xref ref-type="bibr" rid="CR78">2014</xref>).</p>
</sec>
<sec id="Sec17">
<title>Western blotting analysis and Immunostaining</title>
<p>MeCP2 antibody was prepared as previously described (Hu et al., <xref ref-type="bibr" rid="CR28">2006</xref>). Tubulin antibody and secondary antibodies were from ProteinTech Group. Protein lysates were prepared from rat brain tissues or cultured cells for Western blotting analyses using corresponding antibodies following our previously published protocols with a chemiluminescence HRP detection kit (Millipore) (Guo et al., <xref ref-type="bibr" rid="CR23">2011</xref>; Deng et al., <xref ref-type="bibr" rid="CR14">2015</xref>).</p>
<p>For immunostaining, cells were washed in pre-warmed phosphate-buffered saline (PBS) and fixed in 4% paraformaldehyde (PFA). The fixed cells were permeabilized and blocked with 10% normal goat serum (NGS) plus 0.3% Triton X-100 in PBS, incubated with primary antibody: rabbit anti-beta tubulin antibody (1:70) (PTG). After washing 5 times, the cells were incubated with secondary antibody conjugated to Alexa Fluor® 594 (1:500) (Invitrogen) and stained with 4’,6’-diamidino-2-phenylindole (DAPI; 1 μg/mL). The coverslips were mounted with PermaFluor aqueous mounting medium (Thermo).</p>
</sec>
<sec id="Sec18">
<title>Morphological analyses of axons and dendrites</title>
<p>The images for neurite outgrowth were taken using an inverted fluorescence microscope (Nikon) following a previously published protocols (Gao et al., <xref ref-type="bibr" rid="CR20">2010</xref>). The images for dendrite morphology and dendritic spines were taken using a confocal microscope (Leica SP8); image analyses were carried out following the published protocols (Langhammer et al., <xref ref-type="bibr" rid="CR36">2010</xref>; Srivastava et al., <xref ref-type="bibr" rid="CR60">2011</xref>).</p>
</sec>
<sec id="Sec19">
<title>Statistical analyses</title>
<p>The data was normalized to the control group. Statistical analyses were performed using Mann-Whitney test, between individual groups and two-way ANOVA for comparing distributions. *, <italic>P</italic> &lt; 0.05; **, <italic>P</italic> &lt; 0.01; ***, <italic>P</italic> &lt; 0.001. The bar diagram represents mean values ± SEM.</p>
</sec>
</sec>
<sec sec-type="supplementary-material">
<title>Electronic supplementary material</title>
<sec id="Sec20">
<p>Below is the link to the electronic supplementary material.
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="13238_2016_272_MOESM1_ESM.tif"><caption><p>Supplementary material 1 (TIFF 179 kb)</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="13238_2016_272_MOESM2_ESM.tif"><caption><p>Supplementary material 2 (TIFF 2321 kb)</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM3"><media xlink:href="13238_2016_272_MOESM3_ESM.tif"><caption><p>Supplementary material 3 (TIFF 986 kb)</p></caption></media></supplementary-material></p>
</sec>
</sec>
</body>
<back>
<ack>
<title>ACKNOWLEDGMENTS</title>
<p>We thank members of the Wu lab for helpful suggestions. We thank Dr. Yan Zhu and members of the Wu lab for discussions, suggestions and critical reading of the manuscript. MC, LZ, JL are supported by grants from the National Basic Research Program (973 Program) (No. 2013CB917803) and the National Natural Science Foundation of China (Grant No. 91132710). ZQ is supported by the National Natural Science Foundation of China (Grant Nos. 91432111 and 81527901). KH is supported by the National Natural Science Foundation of China (Grant Nos. 81070907 and 81271255). WM is supported by NIH (F30 NS090893). JYW is supported by NIH (RO1AG033004).</p>
<sec id="FPar1">
<title>
<bold>ABBREVIATIONS</bold>
</title>
<p>MiR-130a, microRNA-130a; miR-130a-inh, microRNA-130a-inhibitor; MECP2, methyl-CpG-binding protein 2; TUNEL, TdT-mediated dUTP nick end labeling; Tuj1, neuronal class III β-tubulin.</p>
</sec>
<sec id="FPar2">
<title>
<bold>Compliance with Ethics Guidelines</bold>
</title>
<p>All authors declare that there is no conflict of interest. All national and institutional guidelines for the care and use of laboratory animals were followed. This work did not involve any studies with human subjects performed by the any of the authors.</p>
</sec>
</ack>
<ref-list id="Bib1">
<title>REFERENCES</title>
<ref id="CR1">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Agarwal</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Bell</surname>
<given-names>GW</given-names>
</name>
<name>
<surname>Nam</surname>
<given-names>J-W</given-names>
</name>
<name>
<surname>Bartel</surname>
<given-names>DP</given-names>
</name>
<name>
<surname>Izaurralde</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Predicting effective microRNA target sites in mammalian mRNAs</article-title>
<source/>eLife
          <year>2015</year>
<volume>4</volume>
<fpage>e05005</fpage>
<pub-id pub-id-type="doi">10.7554/eLife.05005</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amir</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Van den Veyver</surname>
<given-names>IB</given-names>
</name>
<name>
<surname>Wan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tran</surname>
<given-names>CQ</given-names>
</name>
<name>
<surname>Francke</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Zoghbi</surname>
<given-names>HY</given-names>
</name>
</person-group>
<article-title>Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2</article-title>
<source/>Nat Genet
          <year>1999</year>
<volume>23</volume>
<fpage>185</fpage>
<lpage>188</lpage>
<pub-id pub-id-type="doi">10.1038/13810</pub-id>
<pub-id pub-id-type="pmid">10508514</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baek</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Villén</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Shin</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Camargo</surname>
<given-names>FD</given-names>
</name>
<name>
<surname>Gygi</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Bartel</surname>
<given-names>DP</given-names>
</name>
</person-group>
<article-title>The impact of microRNAs on protein output</article-title>
<source/>Nature
          <year>2008</year>
<volume>455</volume>
<fpage>64</fpage>
<lpage>71</lpage>
<pub-id pub-id-type="doi">10.1038/nature07242</pub-id>
<pub-id pub-id-type="pmid">18668037</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bartel</surname>
<given-names>DP</given-names>
</name>
</person-group>
<article-title>MicroRNAs: target recognition and regulatory functions</article-title>
<source/>Cell
          <year>2009</year>
<volume>136</volume>
<fpage>215</fpage>
<lpage>233</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2009.01.002</pub-id>
<pub-id pub-id-type="pmid">19167326</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Betel</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gabow</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Marks</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Sander</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>The microRNA.org resource: targets and expression</article-title>
<source/>Nucleic Acids Res
          <year>2008</year>
<volume>36</volume>
<fpage>D149</fpage>
<lpage>D153</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkm995</pub-id>
<pub-id pub-id-type="pmid">18158296</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chahrour</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jung</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Shaw</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>ST</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zoghbi</surname>
<given-names>HY</given-names>
</name>
</person-group>
<article-title>MeCP2, a key contributor to neurological disease, activates and represses transcription</article-title>
<source/>Science
          <year>2008</year>
<volume>320</volume>
<fpage>1224</fpage>
<lpage>1229</lpage>
<pub-id pub-id-type="doi">10.1126/science.1153252</pub-id>
<pub-id pub-id-type="pmid">18511691</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chao</surname>
<given-names>H-T</given-names>
</name>
<name>
<surname>Zoghbi</surname>
<given-names>HY</given-names>
</name>
<name>
<surname>Rosenmund</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number</article-title>
<source/>Neuron
          <year>2007</year>
<volume>56</volume>
<fpage>58</fpage>
<lpage>65</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2007.08.018</pub-id>
<pub-id pub-id-type="pmid">17920015</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chapleau</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Calfa</surname>
<given-names>GD</given-names>
</name>
<name>
<surname>Lane</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Albertson</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Larimore</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Kudo</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Armstrong</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Percy</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Pozzo-Miller</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Dendritic spine pathologies in hippocampal pyramidal neurons from Rett syndrome brain and after expression of Rett-associated MECP2 mutations</article-title>
<source/>Neurobiol Dis
          <year>2009</year>
<volume>35</volume>
<fpage>219</fpage>
<lpage>233</lpage>
<pub-id pub-id-type="doi">10.1016/j.nbd.2009.05.001</pub-id>
<pub-id pub-id-type="pmid">19442733</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheng</surname>
<given-names>T-L</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>W-H</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>Z</given-names>
</name>
</person-group>
<article-title>MeCP2 suppresses nuclear microRNA processing and dendritic growth by regulating the DGCR8/Drosha complex</article-title>
<source/>Dev Cell
          <year>2014</year>
<volume>28</volume>
<fpage>547</fpage>
<lpage>560</lpage>
<pub-id pub-id-type="doi">10.1016/j.devcel.2014.01.032</pub-id>
<pub-id pub-id-type="pmid">24636259</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coutinho</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Oliveira</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Katz</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Marques</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ataíde</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Miguel</surname>
<given-names>TS</given-names>
</name>
<name>
<surname>Borges</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>MECP2 coding sequence and 3′-UTR variation in 172 unrelated autistic patients</article-title>
<source/>Am J Med Genet B
          <year>2007</year>
<volume>144</volume>
<fpage>475</fpage>
<lpage>483</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.b.30490</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coy</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Sedlacek</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Bächner</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Delius</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Poustka</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>A complex pattern of evolutionary conservation and alternative polyadenylation within the long 3′-untranslated region of the methyl-CpG-binding protein 2 gene (MeCP2) suggests a regulatory role in gene expression</article-title>
<source/>Hum Mol Genet
          <year>1999</year>
<volume>8</volume>
<fpage>1253</fpage>
<lpage>1262</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/8.7.1253</pub-id>
<pub-id pub-id-type="pmid">10369871</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cusack</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Rohn</surname>
<given-names>TT</given-names>
</name>
<name>
<surname>Medeck</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Irwin</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Mercer</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Oxford</surname>
<given-names>JT</given-names>
</name>
</person-group>
<article-title>Suppression of MeCP2β expression inhibits neurite extension in PC12 cells</article-title>
<source/>Exp Cell Res
          <year>2004</year>
<volume>299</volume>
<fpage>442</fpage>
<lpage>453</lpage>
<pub-id pub-id-type="doi">10.1016/j.yexcr.2004.05.035</pub-id>
<pub-id pub-id-type="pmid">15350542</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deng</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Bigio</surname>
<given-names>EH</given-names>
</name>
<name>
<surname>Mesulam</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Fushimi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>JY</given-names>
</name>
</person-group>
<article-title>FUS interacts with HSP60 to promote mitochondrial damage</article-title>
<source/>PloSGenetics
          <year>2015</year>
<volume>11</volume>
<issue>9</issue>
<fpage>e1005357</fpage>
</element-citation>
</ref>
<ref id="CR15">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eda</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Fukushima</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hohjoh</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Alteration of microRNA expression in the process of mouse brain growth</article-title>
<source/>Gene
          <year>2011</year>
<volume>485</volume>
<fpage>46</fpage>
<lpage>52</lpage>
<pub-id pub-id-type="doi">10.1016/j.gene.2011.05.034</pub-id>
<pub-id pub-id-type="pmid">21718763</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ethell</surname>
<given-names>IM</given-names>
</name>
<name>
<surname>Pasquale</surname>
<given-names>EB</given-names>
</name>
</person-group>
<article-title>Molecular mechanisms of dendritic spine development and remodeling</article-title>
<source/>Prog Neurobiol
          <year>2005</year>
<volume>75</volume>
<fpage>161</fpage>
<lpage>205</lpage>
<pub-id pub-id-type="doi">10.1016/j.pneurobio.2005.02.003</pub-id>
<pub-id pub-id-type="pmid">15882774</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feliciano</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Bordey</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bonfanti</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Noncanonical sites of adult neurogenesis in the mammalian brain</article-title>
<source/>Cold Spring Harbor Perspect Biol
          <year>2015</year>
<volume>7</volume>
<fpage>a018846</fpage>
<pub-id pub-id-type="doi">10.1101/cshperspect.a018846</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Finnegan</surname>
<given-names>EF</given-names>
</name>
<name>
<surname>Pasquinelli</surname>
<given-names>AE</given-names>
</name>
</person-group>
<article-title>MicroRNA biogenesis: regulating the regulators</article-title>
<source/>Crit Rev Biochem Mol Biol
          <year>2013</year>
<volume>48</volume>
<fpage>51</fpage>
<lpage>68</lpage>
<pub-id pub-id-type="doi">10.3109/10409238.2012.738643</pub-id>
<pub-id pub-id-type="pmid">23163351</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Futamura</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Monden</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Okabe</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Fujita-Yoshigaki</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yokoyama</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Nishimura</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Trichostatin A inhibits both ras-induced neurite outgrowth of PC12 cells and morphological transformation of NIH3T3 cells</article-title>
<source/>Oncogene
          <year>1995</year>
<volume>10</volume>
<fpage>1119</fpage>
<lpage>1123</lpage>
<pub-id pub-id-type="pmid">7700637</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Joselin</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Kar</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ray</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Bateman</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Goate</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>JY</given-names>
</name>
</person-group>
<article-title>Progranulin promotes neurite outgrowth and neuronal differentiation by regulating GSK-3β</article-title>
<source/>Protein Cell
          <year>2010</year>
<volume>1</volume>
<fpage>552</fpage>
<lpage>562</lpage>
<pub-id pub-id-type="doi">10.1007/s13238-010-0067-1</pub-id>
<pub-id pub-id-type="pmid">21204008</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gessert</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bugner</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Tecza</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pinker</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kühl</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>FMR1/FXR1 and the miRNA pathway are required for eye and neural crest development</article-title>
<source/>Dev Biol
          <year>2010</year>
<volume>341</volume>
<fpage>222</fpage>
<lpage>235</lpage>
<pub-id pub-id-type="doi">10.1016/j.ydbio.2010.02.031</pub-id>
<pub-id pub-id-type="pmid">20197067</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Greco</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Rameshwar</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>MicroRNAs regulate synthesis of the neurotransmitter substance P in human mesenchymal stem cell-derived neuronal cells</article-title>
<source/>Proc Natl Acad Sci
          <year>2007</year>
<volume>104</volume>
<fpage>15484</fpage>
<lpage>15489</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0703037104</pub-id>
<pub-id pub-id-type="pmid">17855557</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Kar</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ray</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Rao</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Bigio</surname>
<given-names>EH</given-names>
</name>
<name>
<surname>Mesulam</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Fushimi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>JY</given-names>
</name>
</person-group>
<article-title>An ALS-associated mutation in the TDP-43 gene enhances protein aggregation, fibril formation and neurotoxicity</article-title>
<source/>Nat Struct Mol Biol
          <year>2011</year>
<volume>18</volume>
<fpage>822</fpage>
<lpage>830</lpage>
<pub-id pub-id-type="doi">10.1038/nsmb.2053</pub-id>
<pub-id pub-id-type="pmid">21666678</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hansen</surname>
<given-names>KF</given-names>
</name>
<name>
<surname>Sakamoto</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Wayman</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Impey</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Obrietan</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Transgenic miR132 alters neuronal spine density and impairs novel object recognition memory</article-title>
<source/>PLoS ONE
          <year>2010</year>
<volume>5</volume>
<fpage>e15497</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0015497</pub-id>
<pub-id pub-id-type="pmid">21124738</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hausser</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zavolan</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Identification and consequences of miRNA–target interactions—beyond repression of gene expression</article-title>
<source/>Nat Rev Genet
          <year>2014</year>
<volume>15</volume>
<fpage>599</fpage>
<lpage>612</lpage>
<pub-id pub-id-type="doi">10.1038/nrg3765</pub-id>
<pub-id pub-id-type="pmid">25022902</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoesel</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Bhujabal</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Przemeck</surname>
<given-names>GK</given-names>
</name>
<name>
<surname>Kurz-Drexler</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Weisenhorn</surname>
<given-names>DMV</given-names>
</name>
<name>
<surname>Angelis</surname>
<given-names>MHD</given-names>
</name>
<name>
<surname>Beckers</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Combination of in silico and in situ hybridisation approaches to identify potential Dll1 associated miRNAs during mouse embryogenesis</article-title>
<source/>Gene Expr Patterns
          <year>2010</year>
<volume>10</volume>
<fpage>265</fpage>
<lpage>273</lpage>
<pub-id pub-id-type="doi">10.1016/j.gep.2010.06.002</pub-id>
<pub-id pub-id-type="pmid">20558326</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Nan</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Bird</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>Testing for association between MeCP2 and the brahma-associated SWI/SNF chromatin-remodeling complex</article-title>
<source/>Nat Genet
          <year>2006</year>
<volume>38</volume>
<issue>9</issue>
<fpage>962</fpage>
<lpage>964</lpage>
<pub-id pub-id-type="doi">10.1038/ng0906-962</pub-id>
<pub-id pub-id-type="pmid">16940996</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Im</surname>
<given-names>H-I</given-names>
</name>
<name>
<surname>Kenny</surname>
<given-names>PJ</given-names>
</name>
</person-group>
<article-title>MicroRNAs in neuronal function and dysfunction</article-title>
<source/>Trends Neurosci
          <year>2012</year>
<volume>35</volume>
<fpage>325</fpage>
<lpage>334</lpage>
<pub-id pub-id-type="doi">10.1016/j.tins.2012.01.004</pub-id>
<pub-id pub-id-type="pmid">22436491</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ash</surname>
<given-names>RT</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Suter</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Ferguson</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Rudy</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Torsky</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Chao</surname>
<given-names>H-T</given-names>
</name>
<name>
<surname>Zoghbi</surname>
<given-names>HY</given-names>
</name>
</person-group>
<article-title>Dendritic arborization and spine dynamics are abnormal in the mouse model of MECP2 duplication syndrome</article-title>
<source/>J Neurosci
          <year>2013</year>
<volume>33</volume>
<fpage>19518</fpage>
<lpage>19533</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.1745-13.2013</pub-id>
<pub-id pub-id-type="pmid">24336718</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jones</surname>
<given-names>PL</given-names>
</name>
<name>
<surname>Veenstra</surname>
<given-names>GCJ</given-names>
</name>
<name>
<surname>Wade</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Vermaak</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kass</surname>
<given-names>SU</given-names>
</name>
<name>
<surname>Landsberger</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Strouboulis</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wolffe</surname>
<given-names>AP</given-names>
</name>
</person-group>
<article-title>Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription</article-title>
<source/>Nat Genet
          <year>1998</year>
<volume>19</volume>
<fpage>187</fpage>
<lpage>191</lpage>
<pub-id pub-id-type="doi">10.1038/561</pub-id>
<pub-id pub-id-type="pmid">9620779</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jugloff</surname>
<given-names>DG</given-names>
</name>
<name>
<surname>Jung</surname>
<given-names>BP</given-names>
</name>
<name>
<surname>Purushotham</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Logan</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Eubanks</surname>
<given-names>JH</given-names>
</name>
</person-group>
<article-title>Increased dendritic complexity and axonal length in cultured mouse cortical neurons overexpressing methyl-CpG-binding protein MeCP2</article-title>
<source/>Neurobiol Dis
          <year>2005</year>
<volume>19</volume>
<fpage>18</fpage>
<lpage>27</lpage>
<pub-id pub-id-type="doi">10.1016/j.nbd.2004.11.002</pub-id>
<pub-id pub-id-type="pmid">15837557</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krek</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Grün</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Poy</surname>
<given-names>MN</given-names>
</name>
<name>
<surname>Wolf</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Rosenberg</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Epstein</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>MacMenamin</surname>
<given-names>P</given-names>
</name>
<name>
<surname>da Piedade</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Gunsalus</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Stoffel</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Combinatorial microRNA target predictions</article-title>
<source/>Nat Genet
          <year>2005</year>
<volume>37</volume>
<fpage>495</fpage>
<lpage>500</lpage>
<pub-id pub-id-type="doi">10.1038/ng1536</pub-id>
<pub-id pub-id-type="pmid">15806104</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kutzing</surname>
<given-names>MK</given-names>
</name>
<name>
<surname>Langhammer</surname>
<given-names>CG</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Lakdawala</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Firestein</surname>
<given-names>BL</given-names>
</name>
</person-group>
<article-title>Automated Sholl analysis of digitized neuronal morphology at multiple scales</article-title>
<source/>J Vis Exp.
          <year>2010</year>
<volume>45</volume>
<fpage>2354</fpage>
<pub-id pub-id-type="pmid">21113115</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Langhammer</surname>
<given-names>CG</given-names>
</name>
<name>
<surname>Previtera</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Sweet</surname>
<given-names>ES</given-names>
</name>
<name>
<surname>Sran</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Firestein</surname>
<given-names>BL</given-names>
</name>
</person-group>
<article-title>Automated Sholl analysis of digitized neuronal morphology at multiple scales: whole cell Sholl analysis versus Sholl analysis of arbor subregions</article-title>
<source/>Cytom. A
          <year>2010</year>
<volume>77</volume>
<fpage>1160</fpage>
<lpage>1168</lpage>
<pub-id pub-id-type="doi">10.1002/cyto.a.20954</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lefebvre</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Sanes</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Kay</surname>
<given-names>JN</given-names>
</name>
</person-group>
<article-title>Development of dendritic form and function</article-title>
<source/>Annu Rev Cell Dev Biol
          <year>2015</year>
<volume>31</volume>
<fpage>741</fpage>
<lpage>777</lpage>
<pub-id pub-id-type="doi">10.1146/annurev-cellbio-100913-013020</pub-id>
<pub-id pub-id-type="pmid">26422333</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lewis</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Meehan</surname>
<given-names>RR</given-names>
</name>
<name>
<surname>Henzel</surname>
<given-names>WJ</given-names>
</name>
<name>
<surname>Maurer-Fogy</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Jeppesen</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Bird</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA</article-title>
<source/>Cell
          <year>1992</year>
<volume>69</volume>
<fpage>905</fpage>
<lpage>914</lpage>
<pub-id pub-id-type="doi">10.1016/0092-8674(92)90610-O</pub-id>
<pub-id pub-id-type="pmid">1606614</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lombardi</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Zoghbi</surname>
<given-names>HY</given-names>
</name>
</person-group>
<article-title>MECP2 disorders: from the clinic to mice and back</article-title>
<source/>J Clin Investig
          <year>2015</year>
<volume>125</volume>
<fpage>2914</fpage>
<pub-id pub-id-type="doi">10.1172/JCI78167</pub-id>
<pub-id pub-id-type="pmid">26237041</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maunakea</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Chepelev</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition</article-title>
<source/>Cell Res
          <year>2013</year>
<volume>23</volume>
<fpage>1256</fpage>
<lpage>1269</lpage>
<pub-id pub-id-type="doi">10.1038/cr.2013.110</pub-id>
<pub-id pub-id-type="pmid">23938295</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McGowan</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Pang</surname>
<given-names>ZP</given-names>
</name>
</person-group>
<article-title>Regulatory functions and pathological relevance of the MECP2 3′-UTR in the central nervous system</article-title>
<source/>Cell Regen
          <year>2015</year>
<volume>4</volume>
<fpage>1</fpage>
<pub-id pub-id-type="doi">10.1186/s13619-015-0023-x</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McNeill</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Van Vactor</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>MicroRNAs shape the neuronal landscape</article-title>
<source/>Neuron
          <year>2012</year>
<volume>75</volume>
<fpage>363</fpage>
<lpage>379</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2012.07.005</pub-id>
<pub-id pub-id-type="pmid">22884321</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Merson</surname>
<given-names>TD</given-names>
</name>
<name>
<surname>Bourne</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>Endogenous neurogenesis following ischaemic brain injury: insights for therapeutic strategies</article-title>
<source/>Int J Biochem Cell Biol
          <year>2014</year>
<volume>56</volume>
<fpage>4</fpage>
<lpage>19</lpage>
<pub-id pub-id-type="doi">10.1016/j.biocel.2014.08.003</pub-id>
<pub-id pub-id-type="pmid">25128862</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Na</surname>
<given-names>ES</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>ED</given-names>
</name>
<name>
<surname>Kavalali</surname>
<given-names>ET</given-names>
</name>
<name>
<surname>Monteggia</surname>
<given-names>LM</given-names>
</name>
</person-group>
<article-title>The impact of MeCP2 loss-or gain-of-function on synaptic plasticity</article-title>
<source/>Neuropsychopharmacology
          <year>2013</year>
<volume>38</volume>
<fpage>212</fpage>
<lpage>219</lpage>
<pub-id pub-id-type="doi">10.1038/npp.2012.116</pub-id>
<pub-id pub-id-type="pmid">22781840</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nan</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>H-H</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Laherty</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Turner</surname>
<given-names>BM</given-names>
</name>
<name>
<surname>Eisenman</surname>
<given-names>RN</given-names>
</name>
<name>
<surname>Bird</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex</article-title>
<source/>Nature
          <year>1998</year>
<volume>393</volume>
<fpage>386</fpage>
<lpage>389</lpage>
<pub-id pub-id-type="doi">10.1038/30764</pub-id>
<pub-id pub-id-type="pmid">9620804</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pelka</surname>
<given-names>GJ</given-names>
</name>
<name>
<surname>Watson</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Christodoulou</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Tam</surname>
<given-names>PP</given-names>
</name>
</person-group>
<article-title>Distinct expression profiles of Mecp2 transcripts with different lengths of 3′-UTR in the brain and visceral organs during mouse development</article-title>
<source/>Genomics
          <year>2005</year>
<volume>85</volume>
<fpage>441</fpage>
<lpage>452</lpage>
<pub-id pub-id-type="doi">10.1016/j.ygeno.2004.12.002</pub-id>
<pub-id pub-id-type="pmid">15780747</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Persengiev</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Kilpatrick</surname>
<given-names>DL</given-names>
</name>
</person-group>
<article-title>Nerve growth factor induced differentiation of neuronal cells requires gene methylation</article-title>
<source/>NeuroReport
          <year>1996</year>
<volume>8</volume>
<fpage>227</fpage>
<lpage>231</lpage>
<pub-id pub-id-type="doi">10.1097/00001756-199612200-00046</pub-id>
<pub-id pub-id-type="pmid">9051786</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Phillips</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pozzo-Miller</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Dendritic spine dysgenesis in autism related disorders</article-title>
<source/>Neurosci Lett
          <year>2015</year>
<volume>601</volume>
<fpage>30</fpage>
<lpage>40</lpage>
<pub-id pub-id-type="doi">10.1016/j.neulet.2015.01.011</pub-id>
<pub-id pub-id-type="pmid">25578949</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poluch</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Juliano</surname>
<given-names>SL</given-names>
</name>
</person-group>
<article-title>Fine-tuning of neurogenesis is essential for the evolutionary expansion of the cerebral cortex</article-title>
<source/>Cereb Cortex
          <year>2015</year>
<volume>25</volume>
<fpage>346</fpage>
<lpage>364</lpage>
<pub-id pub-id-type="doi">10.1093/cercor/bht232</pub-id>
<pub-id pub-id-type="pmid">23968831</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robinson</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Guy</surname>
<given-names>J</given-names>
</name>
<name>
<surname>McKay</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Brockett</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Spike</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Selfridge</surname>
<given-names>J</given-names>
</name>
<name>
<surname>De Sousa</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Merusi</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Riedel</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Bird</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Morphological and functional reversal of phenotypes in a mouse model of Rett syndrome</article-title>
<source/>Brain
          <year>2012</year>
<volume>135</volume>
<fpage>2699</fpage>
<lpage>2710</lpage>
<pub-id pub-id-type="doi">10.1093/brain/aws096</pub-id>
<pub-id pub-id-type="pmid">22525157</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rosenfeld</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Ballif</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Torchia</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Sahoo</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ravnan</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Schultz</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Lamb</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bejjani</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Shaffer</surname>
<given-names>LG</given-names>
</name>
</person-group>
<article-title>Copy number variations associated with autism spectrum disorders contribute to a spectrum of neurodevelopmental disorders</article-title>
<source/>Genet Med
          <year>2010</year>
<volume>12</volume>
<fpage>694</fpage>
<lpage>702</lpage>
<pub-id pub-id-type="doi">10.1097/GIM.0b013e3181f0c5f3</pub-id>
<pub-id pub-id-type="pmid">20808228</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Santos</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Temudo</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Oliveira</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Vieira</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Fen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sommer</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Maciel</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Analysis of highly conserved regions of the 3′-UTR of MECP2 gene in patients with clinical diagnosis of Rett syndrome and other disorders associated with mental retardation</article-title>
<source/>Dis Mark
          <year>2008</year>
<volume>24</volume>
<fpage>319</fpage>
<lpage>324</lpage>
<pub-id pub-id-type="doi">10.1155/2008/738401</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schoenfeld</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Cameron</surname>
<given-names>HA</given-names>
</name>
</person-group>
<article-title>Adult neurogenesis and mental illness</article-title>
<source/>Neuropsychopharmacology
          <year>2015</year>
<volume>40</volume>
<fpage>113</fpage>
<lpage>128</lpage>
<pub-id pub-id-type="doi">10.1038/npp.2014.230</pub-id>
<pub-id pub-id-type="pmid">25178407</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Selemon</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zecevic</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Schizophrenia: a tale of two critical periods for prefrontal cortical development</article-title>
<source/>Transl Psychiatry
          <year>2015</year>
<volume>5</volume>
<fpage>e623</fpage>
<pub-id pub-id-type="doi">10.1038/tp.2015.115</pub-id>
<pub-id pub-id-type="pmid">26285133</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Y-H</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X-H</given-names>
</name>
<name>
<surname>Chiang</surname>
<given-names>VL</given-names>
</name>
</person-group>
<article-title>Poly (T) adaptor RT-PCR. In next-generation MicroRNA expression profiling technology</article-title>
<source/>Methods Mol Biol
          <year>2012</year>
<volume>822</volume>
<fpage>53</fpage>
<lpage>66</lpage>
<pub-id pub-id-type="doi">10.1007/978-1-61779-427-8_4</pub-id>
<pub-id pub-id-type="pmid">22144191</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shibayama</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Cook</surname>
<given-names>EH</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Glanzmann</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Craddock</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>IR</given-names>
</name>
<name>
<surname>Goldman</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Heston</surname>
<given-names>LL</given-names>
</name>
<name>
<surname>Sommer</surname>
<given-names>SS</given-names>
</name>
</person-group>
<article-title>MECP2 structural and 3′-UTR variants in schizophrenia, autism and other psychiatric diseases: A possible association with autism</article-title>
<source/>Am J Med Genet B
          <year>2004</year>
<volume>128</volume>
<fpage>50</fpage>
<lpage>53</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.b.30016</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shigehiko</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Takeshi</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Stimulatory effects of substance P and nerve growth factor (NGF) on neurite outgrowth in embryonic chick dorsal root ganglia</article-title>
<source/>Neuropharmacology
          <year>1978</year>
<volume>17</volume>
<fpage>73</fpage>
<lpage>76</lpage>
<pub-id pub-id-type="doi">10.1016/0028-3908(78)90176-4</pub-id>
<pub-id pub-id-type="pmid">206856</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Søe</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Møller</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Dufva</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Holmstrøm</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>A sensitive alternative for microRNA in situ hybridizations using probes of 2-O-methyl RNA+ LNA</article-title>
<source/>J Histochem Cytochem
          <year>2011</year>
<volume>59</volume>
<fpage>661</fpage>
<lpage>672</lpage>
<pub-id pub-id-type="doi">10.1369/0022155411409411</pub-id>
<pub-id pub-id-type="pmid">21525189</pub-id>
</element-citation>
</ref>
<ref id="CR60">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Srivastava</surname>
<given-names>DP</given-names>
</name>
<name>
<surname>Woolfrey</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Penzes</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Analysis of dendritic spine morphology in cultured CNS neurons</article-title>
<source/>J Vis Exp.
          <year>2011</year>
<volume>53</volume>
<fpage>e2794</fpage>
<pub-id pub-id-type="pmid">21775964</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sztainberg</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>H-M</given-names>
</name>
<name>
<surname>Swann</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wan</surname>
<given-names>Y-W</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Rigo</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Zoghbi</surname>
<given-names>HY</given-names>
</name>
</person-group>
<article-title>Reversal of phenotypes in MECP2 duplication mice using genetic rescue or antisense oligonucleotides</article-title>
<source/>Nature
          <year>2015</year>
<volume>528</volume>
<issue>7580</issue>
<fpage>123</fpage>
<lpage>126</lpage>
<pub-id pub-id-type="pmid">26605526</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takano</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Funahashi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Namba</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kaibuchi</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Neuronal polarization</article-title>
<source/>Development.
          <year>2015</year>
<volume>142</volume>
<issue>12</issue>
<fpage>2088</fpage>
<lpage>2093</lpage>
<pub-id pub-id-type="doi">10.1242/dev.114454</pub-id>
<pub-id pub-id-type="pmid">26081570</pub-id>
</element-citation>
</ref>
<ref id="CR63">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tao</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Sherman</surname>
<given-names>NE</given-names>
</name>
<name>
<surname>Martinowich</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Klose</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Schanen</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Jaenisch</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>YE</given-names>
</name>
</person-group>
<article-title>Phosphorylation of MeCP2 at Serine 80 regulates its chromatin association and neurological function</article-title>
<source/>Proc Natl Acad Sci
          <year>2009</year>
<volume>106</volume>
<fpage>4882</fpage>
<lpage>4887</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0811648106</pub-id>
<pub-id pub-id-type="pmid">19225110</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Urdinguio</surname>
<given-names>RGI</given-names>
</name>
<name>
<surname>Fernandez</surname>
<given-names>AF</given-names>
</name>
<name>
<surname>Lopez-Nieva</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Rossi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Huertas</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kulis</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>CG</given-names>
</name>
<name>
<surname>Croce</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Calin</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Esteller</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Disrupted microRNA expression caused by Mecp2 loss in a mouse model of Rett syndrome</article-title>
<source/>Epigenetics.
          <year>2010</year>
<volume>5</volume>
<issue>7</issue>
<fpage>656</fpage>
<lpage>663</lpage>
<pub-id pub-id-type="doi">10.4161/epi.5.7.13055</pub-id>
<pub-id pub-id-type="pmid">20716963</pub-id>
</element-citation>
</ref>
<ref id="CR65">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van Esch</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>MECP2 duplication syndrome</article-title>
<source/>Mol Syndromol
          <year>2011</year>
<volume>2</volume>
<fpage>128</fpage>
<lpage>136</lpage>
<pub-id pub-id-type="pmid">22679399</pub-id>
</element-citation>
</ref>
<ref id="CR66">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vasu</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Anitha</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Thanseem</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yamada</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Wakuda</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Iwata</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tsujii</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sugiyama</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Serum microRNA profiles in children with autism</article-title>
<source/>Molecular autism
          <year>2014</year>
<volume>5</volume>
<fpage>40</fpage>
<pub-id pub-id-type="doi">10.1186/2040-2392-5-40</pub-id>
<pub-id pub-id-type="pmid">25126405</pub-id>
</element-citation>
</ref>
<ref id="CR67">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vidigal</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Ventura</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>The biological functions of miRNAs: lessons from in vivo studies</article-title>
<source/>Trends Cell Biol
          <year>2015</year>
<volume>25</volume>
<fpage>137</fpage>
<lpage>147</lpage>
<pub-id pub-id-type="doi">10.1016/j.tcb.2014.11.004</pub-id>
<pub-id pub-id-type="pmid">25484347</pub-id>
</element-citation>
</ref>
<ref id="CR68">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walker</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Harland</surname>
<given-names>RM</given-names>
</name>
</person-group>
<article-title>Expression of microRNAs during embryonic development of <italic>Xenopus tropicalis</italic></article-title>
<source/>Gene Expression Patterns
          <year>2008</year>
<volume>8</volume>
<fpage>452</fpage>
<lpage>456</lpage>
<pub-id pub-id-type="doi">10.1016/j.gep.2008.03.002</pub-id>
<pub-id pub-id-type="pmid">18440877</pub-id>
</element-citation>
</ref>
<ref id="CR69">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Baraban</surname>
<given-names>SC</given-names>
</name>
</person-group>
<article-title>Granule cell dispersion and aberrant neurogenesis in the adult hippocampus of an LIS1 mutant mouse</article-title>
<source/>Dev Neurosci
          <year>2007</year>
<volume>29</volume>
<fpage>91</fpage>
<lpage>98</lpage>
<pub-id pub-id-type="doi">10.1159/000096214</pub-id>
<pub-id pub-id-type="pmid">17148952</pub-id>
</element-citation>
</ref>
<ref id="CR70">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wegiel</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kuchna</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Nowicki</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Imaki</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Wegiel</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Marchi</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Chauhan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Chauhan</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Bobrowicz</surname>
<given-names>TW</given-names>
</name>
</person-group>
<article-title>The neuropathology of autism: defects of neurogenesis and neuronal migration, and dysplastic changes</article-title>
<source/>Acta Neuropathol
          <year>2010</year>
<volume>119</volume>
<fpage>755</fpage>
<lpage>770</lpage>
<pub-id pub-id-type="doi">10.1007/s00401-010-0655-4</pub-id>
<pub-id pub-id-type="pmid">20198484</pub-id>
</element-citation>
</ref>
<ref id="CR71">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilczynska</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bushell</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>The complexity of miRNA-mediated repression</article-title>
<source/>Cell Death Differ
          <year>2015</year>
<volume>22</volume>
<fpage>22</fpage>
<lpage>33</lpage>
<pub-id pub-id-type="doi">10.1038/cdd.2014.112</pub-id>
<pub-id pub-id-type="pmid">25190144</pub-id>
</element-citation>
</ref>
<ref id="CR72">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Winner</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Winkler</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Adult Neurogenesis in Neurodegenerative Diseases</article-title>
<source/>Cold Spring Harbor Perspect Biol
          <year>2015</year>
<volume>7</volume>
<fpage>a021287</fpage>
<pub-id pub-id-type="doi">10.1101/cshperspect.a021287</pub-id>
</element-citation>
</ref>
<ref id="CR73">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xie</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Mao</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C-Y</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>KOBAS 2.0: a web server for annotation and identification of enriched pathways and diseases</article-title>
<source/>Nucleic Acids Res
          <year>2011</year>
<volume>39</volume>
<fpage>W316</fpage>
<lpage>W322</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkr483</pub-id>
<pub-id pub-id-type="pmid">21715386</pub-id>
</element-citation>
</ref>
<ref id="CR74">
<mixed-citation publication-type="other">Xu X, Miller EC, Pozzo-Miller L (2014) Dendritic spine dysgenesis in Rett syndrome. Frontiers in neuroanatomy 8</mixed-citation>
</ref>
<ref id="CR75">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Young</surname>
<given-names>JI</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>EP</given-names>
</name>
<name>
<surname>Castle</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Crespo-Barreto</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bowman</surname>
<given-names>AB</given-names>
</name>
<name>
<surname>Rose</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Richman</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Berget</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2</article-title>
<source/>Proc Natl Acad Sci USA
          <year>2005</year>
<volume>102</volume>
<fpage>17551</fpage>
<lpage>17558</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0507856102</pub-id>
<pub-id pub-id-type="pmid">16251272</pub-id>
</element-citation>
</ref>
<ref id="CR76">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Gage</surname>
<given-names>FH</given-names>
</name>
</person-group>
<article-title>Mechanisms and functional implications of adult neurogenesis</article-title>
<source/>Cell
          <year>2008</year>
<volume>132</volume>
<fpage>645</fpage>
<lpage>660</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2008.01.033</pub-id>
<pub-id pub-id-type="pmid">18295581</pub-id>
</element-citation>
</ref>
<ref id="CR77">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>W-N</given-names>
</name>
<name>
<surname>Ho</surname>
<given-names>HYH</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>WG</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Savner</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Griffith</surname>
<given-names>EC</given-names>
</name>
</person-group>
<article-title>Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation</article-title>
<source/>Neuron
          <year>2006</year>
<volume>52</volume>
<fpage>255</fpage>
<lpage>269</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2006.09.037</pub-id>
<pub-id pub-id-type="pmid">17046689</pub-id>
</element-citation>
</ref>
<ref id="CR78">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ruan</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Fushimi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Bigio</surname>
<given-names>EH</given-names>
</name>
<name>
<surname>Mesulam</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>JY</given-names>
</name>
</person-group>
<article-title>An ALS-mutant TDP-43 neurotoxic peptide adopts an anti-parallel β-structure and induces TDP-43 redistribution</article-title>
<source/>Hum Mol Genet.
          <year>2014</year>
<volume>23</volume>
<issue>25</issue>
<fpage>6863</fpage>
<lpage>6877</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddu409</pub-id>
<pub-id pub-id-type="pmid">25113748</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>